112 related articles for article (PubMed ID: 12960135)
1. Polilactofate microspheres for Paclitaxel delivery to central nervous system malignancies.
Li KW; Dang W; Tyler BM; Troiano G; Tihan T; Brem H; Walter KA
Clin Cancer Res; 2003 Aug; 9(9):3441-7. PubMed ID: 12960135
[TBL] [Abstract][Full Text] [Related]
2. Enhanced efficacy of a novel controlled release paclitaxel formulation (PACLIMER delivery system) for local-regional therapy of lung cancer tumor nodules in mice.
Harper E; Dang W; Lapidus RG; Garver RI
Clin Cancer Res; 1999 Dec; 5(12):4242-8. PubMed ID: 10632366
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor effect of combination therapy with intratumoral controlled-release paclitaxel (PACLIMER microspheres) and radiation.
Lapidus RG; Dang W; Rosen DM; Gady AM; Zabelinka Y; O'Meally R; DeWeese TL; Denmeade SR
Prostate; 2004 Feb; 58(3):291-8. PubMed ID: 14743469
[TBL] [Abstract][Full Text] [Related]
4. Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma.
Walter KA; Cahan MA; Gur A; Tyler B; Hilton J; Colvin OM; Burger PC; Domb A; Brem H
Cancer Res; 1994 Apr; 54(8):2207-12. PubMed ID: 7909720
[TBL] [Abstract][Full Text] [Related]
5. Local intracerebral administration of Paclitaxel with the paclimer delivery system: toxicity study in a canine model.
Pradilla G; Wang PP; Gabikian P; Li K; Magee CA; Walter KA; Brem H
J Neurooncol; 2006 Jan; 76(2):131-8. PubMed ID: 16284923
[TBL] [Abstract][Full Text] [Related]
6. In vivo performance of implantable biodegradable preparations delivering Paclitaxel and Etanidazole for the treatment of glioma.
Kumar Naraharisetti P; Yung Sheng Ong B; Wei Xie J; Kam Yiu Lee T; Wang CH; Sahinidis NV
Biomaterials; 2007 Feb; 28(5):886-94. PubMed ID: 17067667
[TBL] [Abstract][Full Text] [Related]
7. Treatment of malignant gliomas with mitoxantrone-loaded poly (lactide-co-glycolide) microspheres.
Yemisci M; Bozdag S; Cetin M; Söylemezoglu F; Capan Y; Dalkara T; Vural I
Neurosurgery; 2006 Dec; 59(6):1296-302; discussion 1302-3. PubMed ID: 17277693
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant treatment with locally delivered OncoGel delays the onset of paresis after surgical resection of experimental spinal column metastasis.
Gok B; McGirt MJ; Sciubba DM; Garces-Ambrossi G; Nelson C; Noggle J; Bydon A; Witham TF; Wolinsky JP; Gokaslan ZL
Neurosurgery; 2009 Jul; 65(1):193-9; discussion 199-200. PubMed ID: 19574842
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable microfiber implants delivering paclitaxel for post-surgical chemotherapy against malignant glioma.
Ranganath SH; Wang CH
Biomaterials; 2008 Jul; 29(20):2996-3003. PubMed ID: 18423584
[TBL] [Abstract][Full Text] [Related]
10. A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer) in recurrent ovarian cancer: a Gynecologic Oncology Group study.
Armstrong DK; Fleming GF; Markman M; Bailey HH
Gynecol Oncol; 2006 Nov; 103(2):391-6. PubMed ID: 16626792
[TBL] [Abstract][Full Text] [Related]
11. The use of submicron/nanoscale PLGA implants to deliver paclitaxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma in mice.
Ranganath SH; Fu Y; Arifin DY; Kee I; Zheng L; Lee HS; Chow PK; Wang CH
Biomaterials; 2010 Jul; 31(19):5199-207. PubMed ID: 20350766
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitization of malignant gliomas following intracranial delivery of paclitaxel biodegradable polymer microspheres.
Gabikian P; Tyler BM; Zhang I; Li KW; Brem H; Walter KA
J Neurosurg; 2014 May; 120(5):1078-85. PubMed ID: 24605841
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo characterization of a novel biocompatible polymer-lipid implant system for the sustained delivery of paclitaxel.
Ho EA; Vassileva V; Allen C; Piquette-Miller M
J Control Release; 2005 May; 104(1):181-91. PubMed ID: 15866344
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of paclitaxel released from bio-adhesive polymer microspheres on model superficial bladder cancer.
Le Visage C; Rioux-Leclercq N; Haller M; Breton P; Malavaud B; Leong K
J Urol; 2004 Mar; 171(3):1324-9. PubMed ID: 14767342
[TBL] [Abstract][Full Text] [Related]
15. Prevention of local tumor growth with paclitaxel-loaded microspheres.
Azouz SM; Walpole J; Amirifeli S; Taylor KN; Grinstaff MW; Colson YL
J Thorac Cardiovasc Surg; 2008 May; 135(5):1014-21. PubMed ID: 18455578
[TBL] [Abstract][Full Text] [Related]
16. Magnetic paclitaxel nanoparticles inhibit glioma growth and improve the survival of rats bearing glioma xenografts.
Zhao M; Liang C; Li A; Chang J; Wang H; Yan R; Zhang J; Tai J
Anticancer Res; 2010 Jun; 30(6):2217-23. PubMed ID: 20651372
[TBL] [Abstract][Full Text] [Related]
17. Microparticles developed by electrohydrodynamic atomization for the local delivery of anticancer drug to treat C6 glioma in vitro.
Xie J; Marijnissen JC; Wang CH
Biomaterials; 2006 Jun; 27(17):3321-32. PubMed ID: 16490248
[TBL] [Abstract][Full Text] [Related]
18. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres.
Liu J; Meisner D; Kwong E; Wu XY; Johnston MR
Biomaterials; 2007 Jul; 28(21):3236-44. PubMed ID: 17434581
[TBL] [Abstract][Full Text] [Related]
19. Mathematical modeling and optimization of drug delivery from intratumorally injected microspheres.
Tzafriri AR; Lerner EI; Flashner-Barak M; Hinchcliffe M; Ratner E; Parnas H
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):826-34. PubMed ID: 15701873
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain.
Fung LK; Ewend MG; Sills A; Sipos EP; Thompson R; Watts M; Colvin OM; Brem H; Saltzman WM
Cancer Res; 1998 Feb; 58(4):672-84. PubMed ID: 9485020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]